Claire Geddes News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Claire geddes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Claire Geddes Today - Breaking & Trending Today

40 Years of City Weekly—Volume 17: 2000 to 2001

City Weekly Rewind ....

United States , Capitol Hill , University Of Utah , Salt Lake City , Salt Lake , Mary Dickson , Georgew Bush , Nesreen Khashan , Ralph Nader , Alexander Nibley , Deborah Bott , Al Gore , Katharine Biele , Greg Parrish , Franke Moss , Betsy Wolf , Anne Golden , Scott Renshaw , John Saltas , Varun Gandhi , Jeff Fox , Christopher Smart , Ben Fulton , Mike Leavitt , Claire Geddes , Bruce Baird ,

Dufftown renaissance: Farmers market proves to be a roaring success

Against the backdrop of the uncertain pandemic climate, the renaissance of Dufftown continues. In July, a farmers market was launched. ....

United Kingdom , Andrew Geddes , Caitlin Barnes , Stewart Mackie , Claire Geddes , Lettoch Farm Coffee Company , Mortlach Development , Mortlach Development Trust , Mortlach Memorial , Farm Coffee , Lettoch Farm Coffee ,

Locanabio Announces Upcoming Preclinical Data Presentations at American Society of Gene and Cell Therapy Annual Meeting

Locanabio Announces Upcoming Preclinical Data Presentations at American Society of Gene and Cell Therapy Annual Meeting
News provided by
Share this article
Share this article
SAN DIEGO, May 5, 2021 /PRNewswire/ Locanabio, Inc., an RNA-targeting gene therapy company focused on developing life-changing therapies for patients with severe neurodegenerative, neuromuscular and retinal diseases, today announced that new data from its preclinical research will be highlighted in oral and poster presentations at the 24th Annual American Society of Gene and Cell Therapy (ASGCT) Meeting, taking place virtually from May 11-14, 2021. The presentations include results from a preclinical
in vivo study showing a novel PUF RNA-binding protein system delivered via an adeno-associated virus serotype 9 (AAV9) vector is safe and effective in eliminating toxic CUG repeats in a mouse model of myotonic dystrophy type 1 (DM1). Data also provide insights on the potential of a unique ....

United States , Haydee Gutierrez , Dimitrios Zisoulis , Nandini Narayan , Scott Davis , Ranjan Batra , Shawn Lee , Greg Nachtrab , Dan Gibbs , Alistair Wilson , Dimitrios Angelis , Daniela Martino Roth , Claire Geddes , Daniela Roth , American Society Of Gene , Locanabio Inc , Berry Company , Annual American Society , Cell Therapy , System Corrects Molecular , Functional Defects , Myotonic Dystrophy Type , Aaron Berlin , Targeting Gene Therapy Approach , Syndrome Type , Rea Lardelli ,